2019/11/14 by MeLisa R. Creamer, Teresa W. Wang, Stephen Babb +5 · 942 citations
Medicine · #Smoking Behavior and Cessation #Medicine #Smokeless tobacco #National Health Interview Survey #Environmental health #Tobacco product #Population #Smoking cessation #Psychological intervention #Tobacco harm reduction #National Health and Nutrition Examination Survey #Death certificate #Quitline #Young adult #Gerontology #Demography #Tobacco use #Cause of death #Disease #Psychiatry
paper · pdf · doi:10.15585/mmwr.mm6845a2
published in MMWR Morbidity and Mortality Weekly Report 68(45), 1013-1019 (Centers for Disease Control and Prevention)
openalex publication_date 2019/11/14 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/30
Cigarette smoking is the leading cause of preventable disease and death in the United States (1). The prevalence of adult cigarette smoking has declined in recent years to 14.0% in 2017 (2). However, an array of new tobacco products, including e-cigarettes, has entered the U.S. market (3). To assess recent national estimates of tobacco product use among U.S. adults aged ≥18 years, CDC, the Food and Drug Administration (FDA), and the National Cancer Institute analyzed data from the 2018 National Health Interview Survey (NHIS). In 2018, an estimated 49.1 million U.S. adults (19.7%) reported currently using any tobacco product, including cigarettes (13.7%), cigars (3.9%), e-cigarettes (3.2%), smokeless tobacco (2.4%), and pipes* (1.0%). Most tobacco product users (83.8%) reported using combustible products (cigarettes, cigars, or pipes), and 18.8% reported using two or more tobacco products. The prevalence of any current tobacco product use was higher in males; adults aged ≤65 years; non-Hispanic American Indian/Alaska Natives; those with a General Educational Development certificate (GED); those with an annual household income <35,000; lesbian, gay, or bisexual adults; uninsured adults; those with a disability or limitation; and those with serious psychological distress. The prevalence of e-cigarette and smokeless tobacco use increased during 2017-2018. During 2009-2018, there were significant increases in all three cigarette cessation indicators (quit attempts, recent cessation, and quit ratio). Implementing comprehensive population-based interventions in coordination with regulation of the manufacturing, marketing, and distribution of all tobacco products can reduce tobacco-related disease and death in the United States (1,4).